Objective:
To highlight the importance of regulatory advocacy and strategies for controlling supply costs in ophthalmic ambulatory surgery centers (ASCs).
Approach:
- Regulatory Advocacy: OOSS collected comments on the proposed 2027 rule from the ophthalmic community and submitted a draft to CMS.
- OOSS Symposium: The 2026 OOSS Symposium on October 10 in New Orleans will provide insights on clinical, operational, and financial performance for ASC leaders.
- GPO Overview: EyeProGPO provides tailored solutions for ophthalmic ASCs to control costs and improve profitability through aggregated purchasing power.
Key Findings:
- EyeProGPO serves over 8,300 members, offering access to prenegotiated pricing and reducing supply chain costs.
- Membership in EyeProGPO is free, with no purchase obligations, and focuses exclusively on ophthalmology.
- The organization provides workflow optimization tools, educational resources, and networking opportunities.
Limitations:
- The article does not provide specific data on cost savings achieved by ASCs using EyeProGPO.
- No comparative analysis of EyeProGPO versus other GPOs is presented.
Conclusion:
EyeProGPO's focus on ophthalmology and its tailored solutions position it as a strategic partner for ASCs aiming to optimize performance.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.